Varex Imaging Corporation (VREX)
NASDAQ: VREX · IEX Real-Time Price · USD
14.20
-0.24 (-1.66%)
At close: Jul 19, 2024, 4:00 PM
14.26
+0.06 (0.42%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Varex Imaging Revenue
Varex Imaging had revenue of $855.80M in the twelve months ending March 29, 2024. Revenue in the quarter ending March 29, 2024 was $206.20M. In the fiscal year ending September 29, 2023, Varex Imaging had annual revenue of $893.40M with 3.96% growth.
Revenue (ttm)
$855.80M
Revenue Growth
-2.72%
P/S Ratio
0.68
Revenue / Employee
$356,583
Employees
2,400
Market Cap
580.78M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 29, 2023 | 893.40M | 34.00M | 3.96% |
Sep 30, 2022 | 859.40M | 41.30M | 5.05% |
Oct 1, 2021 | 818.10M | 79.80M | 10.81% |
Oct 2, 2020 | 738.30M | -42.30M | -5.42% |
Sep 27, 2019 | 780.60M | 7.20M | 0.93% |
Sep 28, 2018 | 773.40M | 75.30M | 10.79% |
Sep 29, 2017 | 698.10M | 78.00M | 12.58% |
Sep 30, 2016 | 620.10M | -12.20M | -1.93% |
Sep 30, 2015 | 632.30M | -52.90M | -7.72% |
Sep 26, 2014 | 685.20M | 15.40M | 2.30% |
Sep 30, 2013 | 669.80M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Emergent BioSolutions | 1.19B |
Orthofix Medical | 760.05M |
Pharming Group | 280.83M |
Surmodics | 142.96M |
IRadimed | 67.69M |
Verve Therapeutics | 16.05M |
Allogene Therapeutics | 65.00K |
VREX News
- 4 days ago - Varex Schedules Third Quarter Fiscal Year 2024 Earnings Release and Conference Call - Business Wire
- 7 weeks ago - Varex Management to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Varex Announces Financial Results for Second Quarter Fiscal Year 2024 - Business Wire
- 3 months ago - Varex Schedules Second Quarter Fiscal Year 2024 Earnings Release and Conference Call - Business Wire
- 4 months ago - Varex Announces Closing of Revolving Credit Facility of $155 Million - Business Wire
- 5 months ago - Varex to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference - Business Wire
- 5 months ago - Varex Announces Financial Results for First Quarter Fiscal Year 2024 - Business Wire
- 6 months ago - Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call - Business Wire